Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine

Dermatol Surg. 2009 Oct;35(10):1567-72. doi: 10.1111/j.1524-4725.2009.01277.x. Epub 2009 Jul 28.
No abstract available

MeSH terms

  • Administration, Oral
  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Capecitabine
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Middle Aged
  • Organ Transplantation*
  • Precancerous Conditions / etiology
  • Precancerous Conditions / prevention & control*
  • Skin Neoplasms / etiology
  • Skin Neoplasms / prevention & control*

Substances

  • Antimetabolites, Antineoplastic
  • Immunosuppressive Agents
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil